160 related articles for article (PubMed ID: 28631776)
1. An overview of pre-clinical studies on the effects of (-)-epigallocatechin-3-gallate, a catechin found in green tea, in treatment of pancreatic cancer.
Bimonte S; Cascella M; Leongito M; Palaia R; Caliendo D; Izzo F; Cuomo A
Recenti Prog Med; 2017 Jun; 108(6):282-287. PubMed ID: 28631776
[TBL] [Abstract][Full Text] [Related]
2. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer.
Almatroodi SA; Almatroudi A; Khan AA; Alhumaydhi FA; Alsahli MA; Rahmani AH
Molecules; 2020 Jul; 25(14):. PubMed ID: 32660101
[TBL] [Abstract][Full Text] [Related]
3. Effects of the Green Tea Polyphenol Epigallocatechin-3-Gallate on Glioma: A Critical Evaluation of the Literature.
Le CT; Leenders WPJ; Molenaar RJ; van Noorden CJF
Nutr Cancer; 2018 Apr; 70(3):317-333. PubMed ID: 29570984
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy.
Granja A; Pinheiro M; Reis S
Nutrients; 2016 May; 8(5):. PubMed ID: 27213442
[TBL] [Abstract][Full Text] [Related]
5. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
Yamauchi R; Sasaki K; Yoshida K
Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
[TBL] [Abstract][Full Text] [Related]
6. Novel mechanisms of anticancer activities of green tea component epigallocatechin- 3-gallate.
Zhang L; Wei Y; Zhang J
Anticancer Agents Med Chem; 2014; 14(6):779-86. PubMed ID: 24851882
[TBL] [Abstract][Full Text] [Related]
7. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells.
Qanungo S; Das M; Haldar S; Basu A
Carcinogenesis; 2005 May; 26(5):958-67. PubMed ID: 15705601
[TBL] [Abstract][Full Text] [Related]
9. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC
Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482
[TBL] [Abstract][Full Text] [Related]
10. Quantitative comparison of cancer and normal cell adhesion using organosilane monolayer templates: an experimental study on the anti-adhesion effect of green-tea catechins.
Sakamoto R; Kakinuma E; Masuda K; Takeuchi Y; Ito K; Iketaki K; Matsuzaki T; Nakabayashi S; Yoshikawa HY; Yamamoto H; Sato Y; Tanii T
In Vitro Cell Dev Biol Anim; 2016 Sep; 52(8):799-805. PubMed ID: 27251159
[TBL] [Abstract][Full Text] [Related]
11. Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines.
Ahmed RS; Liu G; Renzetti A; Farshi P; Yang H; Soave C; Saed G; El-Ghoneimy AA; El-Banna HA; Foldes R; Chan TH; Dou QP
J Cell Biochem; 2016 Oct; 117(10):2357-69. PubMed ID: 26950525
[TBL] [Abstract][Full Text] [Related]
12. The role of the mitochondrial oxidative stress in the cytotoxic effects of the green tea catechin, (-)-epigallocatechin-3-gallate, in oral cells.
Tao L; Forester SC; Lambert JD
Mol Nutr Food Res; 2014 Apr; 58(4):665-76. PubMed ID: 24249144
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
[TBL] [Abstract][Full Text] [Related]
14. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
James KD; Forester SC; Lambert JD
Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
[TBL] [Abstract][Full Text] [Related]
15. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
Lecumberri E; Dupertuis YM; Miralbell R; Pichard C
Clin Nutr; 2013 Dec; 32(6):894-903. PubMed ID: 23582951
[TBL] [Abstract][Full Text] [Related]
16. Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery.
Yang QQ; Wei XL; Fang YP; Gan RY; Wang M; Ge YY; Zhang D; Cheng LZ; Corke H
Crit Rev Food Sci Nutr; 2020; 60(8):1243-1264. PubMed ID: 30799648
[TBL] [Abstract][Full Text] [Related]
17. Catechin prodrugs and analogs: a new array of chemical entities with improved pharmacological and pharmacokinetic properties.
Bansal S; Vyas S; Bhattacharya S; Sharma M
Nat Prod Rep; 2013 Oct; 30(11):1438-54. PubMed ID: 24056761
[TBL] [Abstract][Full Text] [Related]
18. Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors.
Liu C; Li P; Qu Z; Xiong W; Liu A; Zhang S
Molecules; 2019 May; 24(9):. PubMed ID: 31058847
[TBL] [Abstract][Full Text] [Related]
19. Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate.
Pan MH; Chiou YS; Wang YJ; Ho CT; Lin JK
Food Funct; 2011 Feb; 2(2):101-10. PubMed ID: 21779554
[TBL] [Abstract][Full Text] [Related]
20. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
